Photocure study supports cost-effectiveness of blue light cystoscopy
Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review
FDB introduces gravimetric content to improve IV medication compounding
Curocell secures full approval for RIMQARTO to enter CAR-T therapy market
European Commission clears first pertuzumab biosimilar in Europe
C-Ray Therapeutics' Copper-64 (Cu-64) Type II DMF gains FDA acceptance
GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation
Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove
Cantargia reports early remission data from nadunolimab trial in MDS and AML